-
1
-
-
30344439138
-
Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy
-
DOI 10.1158/1535-7163.MCT-05-0065
-
Ali S, El-Rayes BF, Sarkar FH, Philip PA. 2005. Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy. Mol Cancer Ther 4:1943-1951. (Pubitemid 43056977)
-
(2005)
Molecular Cancer Therapeutics
, vol.4
, Issue.12
, pp. 1943-1951
-
-
Ali, S.1
El-Rayes, B.F.2
Sarkar, F.H.3
Philip, P.A.4
-
2
-
-
49849102783
-
Apoptosis-inducing effect of erlotinib is potentiated by 3,3′-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer
-
Ali S, Banerjee S, Ahmad A, El-Rayes BF, Philip PA, Sarkar FH. 2008. Apoptosis-inducing effect of erlotinib is potentiated by 3,3′- diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer. Mol Cancer Ther 7:1708-1719.
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 1708-1719
-
-
Ali, S.1
Banerjee, S.2
Ahmad, A.3
El-Rayes, B.F.4
Philip, P.A.5
Sarkar, F.H.6
-
3
-
-
60749086869
-
Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: Novel chemotherapeutic targets in pancreatic endocrine tumors?
-
Bergmann F, Breinig M, Hopfner M, Rieker RJ, Fischer L, Kohler C, Esposito I, Kleeff J, Herpel E, Ehemann V, Friess H, Schirmacher P, Kern MA. 2009. Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: Novel chemotherapeutic targets in pancreatic endocrine tumors? Am J Gastroenterol 104:171-181.
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 171-181
-
-
Bergmann, F.1
Breinig, M.2
Hopfner, M.3
Rieker, R.J.4
Fischer, L.5
Kohler, C.6
Esposito, I.7
Kleeff, J.8
Herpel, E.9
Ehemann, V.10
Friess, H.11
Schirmacher, P.12
Kern, M.A.13
-
4
-
-
43949125509
-
A new prostate cancer therapeutic approach: Combination of androgen ablation with COX-2 inhibitor
-
DOI 10.1002/ijc.23481
-
Cai Y, Lee YF, Li G, Liu S, Bao BY, Huang J, Hsu CL, Chang C. 2008. A new prostate cancer therapeutic approach: Combination of androgen ablation with COX-2 inhibitor. Int J Cancer 123:195-201. (Pubitemid 351705209)
-
(2008)
International Journal of Cancer
, vol.123
, Issue.1
, pp. 195-201
-
-
Cai, Y.1
Lee, Y.-F.2
Li, G.3
Liu, S.4
Bao, B.-Y.5
Huang, J.6
Hsu, C.-L.7
Chang, C.8
-
5
-
-
48249102773
-
Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression
-
Colby JK, Klein RD, McArthur MJ, Conti CJ, Kiguchi K, Kawamoto T, Riggs PK, Pavone AI, Sawicki J, Fischer SM. 2008. Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression. Neoplasia 10:782-796.
-
(2008)
Neoplasia
, vol.10
, pp. 782-796
-
-
Colby, J.K.1
Klein, R.D.2
McArthur, M.J.3
Conti, C.J.4
Kiguchi, K.5
Kawamoto, T.6
Riggs, P.K.7
Pavone, A.I.8
Sawicki, J.9
Fischer, S.M.10
-
6
-
-
36749039760
-
Tyrosine kinase inhibitors in non-small cell lung and pancreatic cancer: The emerging role of erlotinib
-
Dediu M, Median D, Alexandru A, Vremes G, Gal C. 2007. Tyrosine kinase inhibitors in non-small cell lung and pancreatic cancer: The emerging role of erlotinib. J BUON 12(Suppl 1): S137-S149. (Pubitemid 350213826)
-
(2007)
Journal of B.U.ON.
, vol.12
, Issue.SUPPL. 1
-
-
Dediu, M.1
Median, D.2
Alexandru, A.3
Vremes, G.4
Gal, C.5
-
7
-
-
0032423809
-
Epidermal growth factor and its receptor as prognostic indicators in Chinese patients with pancreatic cancer
-
Dong M, Nio Y, Guo KJ, Tamura K, Tian YL, Dong YT. 1998. Epidermal growth factor and its receptor as prognostic indicators in Chinese patients with pancreatic cancer. Anticancer Res 18:4613-4619. (Pubitemid 29042032)
-
(1998)
Anticancer Research
, vol.18
, Issue.6 B
, pp. 4613-4619
-
-
Dong, M.1
Nio, Y.2
Guo, K.-J.3
Tamura, K.4
Tian, Y.-L.5
Dong, Y.-T.6
-
8
-
-
9444296055
-
Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines
-
El-Rayes BF, Ali S, Sarkar FH, Philip PA. 2004. Cyclooxygenase-2- dependent and -independent effects of celecoxib in pancreatic cancer cell lines. Mol Cancer Ther 3:1421-1426. (Pubitemid 39562587)
-
(2004)
Molecular Cancer Therapeutics
, vol.3
, Issue.11
, pp. 1421-1426
-
-
El-Rayes, B.F.1
Ali, S.2
Sarkar, F.H.3
Philip, P.A.4
-
9
-
-
36549082403
-
Toll-Like Receptor-4 Promotes the Development of Colitis-Associated Colorectal Tumors
-
DOI 10.1053/j.gastro.2007.09.008, PII S0016508507016496
-
Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, Krishnareddy S, Hsu D, Xu R, Harpaz N, Dannenberg AJ, Subbaramaiah K, Cooper HS, Itzkowitz SH, Abreu MT. 2007. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133:1869-1881. (Pubitemid 350186162)
-
(2007)
Gastroenterology
, vol.133
, Issue.6
-
-
Fukata, M.1
Chen, A.2
Vamadevan, A.S.3
Cohen, J.4
Breglio, K.5
Krishnareddy, S.6
Hsu, D.7
Xu, R.8
Harpaz, N.9
Dannenberg, A.J.10
Subbaramaiah, K.11
Cooper, H.S.12
Itzkowitz, S.H.13
Abreu, M.T.14
-
10
-
-
55949098253
-
Expression analysis of the prostaglandin E2 production pathway in human pancreatic cancers
-
Hasan S, Satake M, Dawson DW, Funahashi H, Angst E, Go VL, Reber HA, Hines OJ, Eibl G. 2008. Expression analysis of the prostaglandin E2 production pathway in human pancreatic cancers. Pancreas 37:121-127.
-
(2008)
Pancreas
, vol.37
, pp. 121-127
-
-
Hasan, S.1
Satake, M.2
Dawson, D.W.3
Funahashi, H.4
Angst, E.5
Go, V.L.6
Reber, H.A.7
Hines, O.J.8
Eibl, G.9
-
11
-
-
0035984590
-
3,3′-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression
-
Hong C, Kim HA, Firestone GL, Bjeldanes LF. 2002. 3,3′- Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 23:1297-1305.
-
(2002)
Carcinogenesis
, vol.23
, pp. 1297-1305
-
-
Hong, C.1
Kim, H.A.2
Firestone, G.L.3
Bjeldanes, L.F.4
-
12
-
-
67650874081
-
Cancer Statistics, 2009
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. 2009. Cancer Statistics, 2009. CA Cancer J Clin 59:225-249.
-
(2009)
CA Cancer J Clin
, vol.59
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Thun, M.J.6
-
13
-
-
36348978032
-
Glottic versus supraglottic tumors: Differential molecular profile
-
DOI 10.1007/s00405-007-0441-7
-
Kourelis K, Papadas T, Vandoros G, Goumas P, Sotiropoulou-Bonikou G. 2008. Glottic versus supraglottic tumors: Differential molecular profile. Eur Arch Otorhinolaryngol 265:79-84. (Pubitemid 350160370)
-
(2008)
European Archives of Oto-Rhino-Laryngology
, vol.265
, Issue.1
, pp. 79-84
-
-
Kourelis, K.1
Papadas, T.2
Vandoros, G.3
Goumas, P.4
Sotiropoulou-Bonikou, G.5
-
14
-
-
33845950491
-
Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity
-
Lev-Ari S, Starr A, Vexler A, Karaush V, Loew V, Greif J, Fenig E, Aderka D, Ben-Yosef R. 2006. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Res 26:4423-4430. (Pubitemid 46031517)
-
(2006)
Anticancer Research
, vol.26
, Issue.6 B
, pp. 4423-4430
-
-
Lev-Ari, S.1
Starr, A.2
Vexler, A.3
Karaush, V.4
Loew, V.5
Greif, J.6
Fenig, E.7
Aderka, D.8
Ben-Yosef, R.9
-
15
-
-
34548845889
-
Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines
-
DOI 10.1080/07357900701359577, PII 782019629
-
Lev-Ari S, Vexler A, Starr A, Shkenazy-Voghera M, Greif J, Aderka D, Ben-Yosef R. 2007. Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. Cancer Invest 25:411-418. (Pubitemid 47450667)
-
(2007)
Cancer Investigation
, vol.25
, Issue.6
, pp. 411-418
-
-
Lev-Ari, S.1
Vexler, A.2
Starr, A.3
Ashkenazy-Voghera, M.4
Greif, J.5
Aderka, D.6
Ben-Yosef, R.7
-
16
-
-
33947198190
-
Nuclear factor-kappaB (NFkappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy
-
Logan RM, Gibson RJ, Sonis ST, Keefe DM. 2007. Nuclear factor-kappaB (NFkappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncol 43:395-401.
-
(2007)
Oral Oncol
, vol.43
, pp. 395-401
-
-
Logan, R.M.1
Gibson, R.J.2
Sonis, S.T.3
Keefe, D.M.4
-
17
-
-
34247529341
-
Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1
-
DOI 10.1158/1078-0432.CCR-06-1574
-
Mohammad RM, Goustin AS, Aboukameel A, Chen B, Banerjee S, Wang G, Nikolovska-Coleska Z, Wang S, Al-Katib A. 2007. Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1. Clin Cancer Res 13:2226-2235. (Pubitemid 46649892)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.7
, pp. 2226-2235
-
-
Mohammad, R.M.1
Goustin, A.S.2
Aboukameel, A.3
Chen, B.4
Banerjee, S.5
Wang, G.6
Nikolovska-Coleska, Z.7
Wang, S.8
Al-Katib, A.9
-
18
-
-
34249933404
-
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group
-
Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, Ptasynski M, Parulekar W. 2007. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25:1960-1966.
-
(2007)
J Clin Oncol
, vol.25
, pp. 1960-1966
-
-
Moore, M.J.1
Goldstein, D.2
Hamm, J.3
Figer, A.4
Hecht, J.R.5
Gallinger, S.6
Au, H.J.7
Murawa, P.8
Walde, D.9
Wolff, R.A.10
Campos, D.11
Lim, R.12
Ding, K.13
Clark, G.14
Voskoglou-Nomikos, T.15
Ptasynski, M.16
Parulekar, W.17
-
19
-
-
1942469354
-
Identification of an Autoregulatory Feedback Pathway Involving Interleukin-1alpha in Induction of Constitutive NF-kappaB Activation in Pancreatic Cancer Cells
-
DOI 10.1074/jbc.M309789200
-
Niu J, Li Z, Peng B, Chiao PJ. 2004. Identification of an autoregulatory feedback pathway involving interleukin-1alpha in induction of constitutive NF-kappaB activation in pancreatic cancer cells. J Biol Chem 279:16452-16462. (Pubitemid 38509343)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.16
, pp. 16452-16462
-
-
Niu, J.1
Li, Z.2
Peng, B.3
Chiao, P.J.4
-
20
-
-
0036006453
-
2 , transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy
-
DOI 10.1038/nm0302-289
-
Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. 2002. Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 8:289-293. (Pubitemid 34250108)
-
(2002)
Nature Medicine
, vol.8
, Issue.3
, pp. 289-293
-
-
Pai, R.1
Soreghan, B.2
Szabo, I.L.3
Pavelka, M.4
Baatar, D.5
Tarnawski, A.S.6
-
21
-
-
25144432015
-
Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas
-
DOI 10.1038/modpathol.3800427, PII 3800427
-
Papouchado B, Erickson LA, Rohlinger AL, Hobday TJ, Erlichman C, Ames MM, Lloyd RV. 2005. Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas. Mod Pathol 18:1329-1335. (Pubitemid 41348651)
-
(2005)
Modern Pathology
, vol.18
, Issue.10
, pp. 1329-1335
-
-
Papouchado, B.1
Erickson, L.A.2
Rohlinger, A.L.3
Hobday, T.J.4
Erlichman, C.5
Ames, M.M.6
Lloyd, R.V.7
-
22
-
-
35948988561
-
Inactivation of NF-kappaB by 3,3′-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells
-
DOI 10.1158/1535-7163.MCT-07-0336
-
Rahman KM, Ali S, Aboukameel A, Sarkar SH, Wang Z, Philip PA, Sakr WA, Raz A. 2007. Inactivation of NF-kappaB by 3,3′-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells. Mol Cancer Ther 6:2757-2765. (Pubitemid 350064073)
-
(2007)
Molecular Cancer Therapeutics
, vol.6
, Issue.10
, pp. 2757-2765
-
-
Rahman, K.M.W.1
Ali, S.2
Aboukameel, A.3
Sarkar, S.H.4
Wang, Z.5
Philip, P.A.6
Sakr, W.A.7
Raz, A.8
-
23
-
-
0028088840
-
Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent
-
Tiwari RK, Guo L, Bradlow HL, Telang NT, Osborne MP. 1994. Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent. J Natl Cancer Inst 86:126-131. (Pubitemid 24983592)
-
(1994)
Journal of the National Cancer Institute
, vol.86
, Issue.2
, pp. 126-131
-
-
Tiwari, R.K.1
Guo, L.2
Bradlow, H.L.3
Telang, N.T.4
Osborne, M.P.5
-
24
-
-
0033063774
-
The epidermal growth factor receptor and its inhibition in cancer therapy
-
DOI 10.1016/S0163-7258(98)00045-X, PII S016372589800045X
-
Woodburn JR. 1999. The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Ther 82:241-250. (Pubitemid 29255919)
-
(1999)
Pharmacology and Therapeutics
, vol.82
, Issue.2-3
, pp. 241-250
-
-
Woodburn, J.R.1
|